Wuhan Hiteck Biological Pharma Co.,Ltd 300683.SZ Stock
Wuhan Hiteck Biological Pharma Co.,Ltd Price Chart
Wuhan Hiteck Biological Pharma Co.,Ltd 300683.SZ Financial and Trading Overview
Contents
| Wuhan Hiteck Biological Pharma Co.,Ltd stock price | 23.47 CNY |
| Previous Close | 35.47 CNY |
| Open | 35.59 CNY |
| Bid | 36.99 CNY x N/A |
| Ask | 37 CNY x N/A |
| Day's Range | 35.45 - 37.5 CNY |
| 52 Week Range | 33.35 - 50.86 CNY |
| Volume | 1.87M CNY |
| Avg. Volume | 554.12K CNY |
| Market Cap | 4.84B CNY |
| Beta (5Y Monthly) | -0.175684 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.47 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | July 1, 2020 |
| 1y Target Est | N/A |
300683.SZ Valuation Measures
| Enterprise Value | 3.57B CNY |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.3223085 |
| Price/Book (mrq) | 1.8635355 |
| Enterprise Value/Revenue | 5.396 |
| Enterprise Value/EBITDA | 743.926 |
Trading Information
Wuhan Hiteck Biological Pharma Co.,Ltd Stock Price History
| Beta (5Y Monthly) | -0.175684 |
| 52-Week Change | -5.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 50.86 CNY |
| 52 Week Low | 33.35 CNY |
| 50-Day Moving Average | 35.89 CNY |
| 200-Day Moving Average | 37.69 CNY |
300683.SZ Share Statistics
| Avg. Volume (3 month) | 554.12K CNY |
| Avg. Daily Volume (10-Days) | 486.91K CNY |
| Shares Outstanding | 130.89M |
| Float | 71.64M |
| Short Ratio | N/A |
| % Held by Insiders | 49.92% |
| % Held by Institutions | 0.64% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -3.50% |
| Operating Margin (ttm) | -7.45% |
| Gross Margin | 46.52% |
| EBITDA Margin | 0.72% |
Management Effectiveness
| Return on Assets (ttm) | -1.080% |
| Return on Equity (ttm) | -0.79% |
Income Statement
| Revenue (ttm) | 661.06M CNY |
| Revenue Per Share (ttm) | 5.8 CNY |
| Quarterly Revenue Growth (yoy) | -16.60% |
| Gross Profit (ttm) | 333.74M CNY |
| EBITDA | 4.79M CNY |
| Net Income Avi to Common (ttm) | -23192154 CNY |
| Diluted EPS (ttm) | -0.19 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.17B CNY |
| Total Cash Per Share (mrq) | 8.94 CNY |
| Total Debt (mrq) | 69.64M CNY |
| Total Debt/Equity (mrq) | 2.66 CNY |
| Current Ratio (mrq) | 5.66 |
| Book Value Per Share (mrq) | 19.844 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 73.43M CNY |
| Levered Free Cash Flow (ttm) | 313.72M CNY |
Profile of Wuhan Hiteck Biological Pharma Co.,Ltd
| Country | China |
| State | N/A |
| City | Wuhan |
| Address | Hite Science and Technology Park |
| ZIP | 430056 |
| Phone | 86 27 8489 1666 |
| Website | https://www.hiteck.com.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1346 |
Wuhan Hiteck Biological Pharma Co.,Ltd, a biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China. Its products include Jinlujie, a mouse nerve growth factor for injection; omeprazole sodium for injection; cyclic adenosine phosphate; Xinye, an acyclovir dispensable tablets; Bingbing Horse & Dragon, an indomethacin furazolidone suppository drug; Xunkeyuan, a tinidazole suppository drug; and Shufu, a nimodipine sustained release tablets. The company also provides measles virus and rubella virus nucleic acid detection kit; mycoplasma isolation and identification kit and culture tube; bacterial vaginosis rapid detection kit; measles virus IgG antibody detection kit; and coronavirus N-protein detection kit. In addition, it offers Lopinavir and Ritonavir APIs; and intermediates. The company offers its products in the field of nervous system and oncology. Wuhan Hiteck Biological Pharma Co.,Ltd was founded in 1992 and is based in Wuhan, China.
Q&A For Wuhan Hiteck Biological Pharma Co.,Ltd Stock
What is a current 300683.SZ stock price?
Wuhan Hiteck Biological Pharma Co.,Ltd 300683.SZ stock price today per share is 23.47 CNY.
How to purchase Wuhan Hiteck Biological Pharma Co.,Ltd stock?
You can buy 300683.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Wuhan Hiteck Biological Pharma Co.,Ltd?
The stock symbol or ticker of Wuhan Hiteck Biological Pharma Co.,Ltd is 300683.SZ.
Which industry does the Wuhan Hiteck Biological Pharma Co.,Ltd company belong to?
The Wuhan Hiteck Biological Pharma Co.,Ltd industry is Drug Manufacturers-Specialty & Generic.
How many shares does Wuhan Hiteck Biological Pharma Co.,Ltd have in circulation?
The max supply of Wuhan Hiteck Biological Pharma Co.,Ltd shares is 130.89M.
What is Wuhan Hiteck Biological Pharma Co.,Ltd Price to Earnings Ratio (PE Ratio)?
Wuhan Hiteck Biological Pharma Co.,Ltd PE Ratio is now.
What was Wuhan Hiteck Biological Pharma Co.,Ltd earnings per share over the trailing 12 months (TTM)?
Wuhan Hiteck Biological Pharma Co.,Ltd EPS is -0.47 CNY over the trailing 12 months.
Which sector does the Wuhan Hiteck Biological Pharma Co.,Ltd company belong to?
The Wuhan Hiteck Biological Pharma Co.,Ltd sector is Healthcare.